Emily Kopp
KFF Health News
Washington, DC, United States
Contact Emily
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Emily:
The High Cost Of Hope: When The Parallel Interests Of Pharma And Families Collide
Desperate for help in finding a lifesaving drug for a fatal genetic disease, families banded together to fund early research and then worked with drug companies on clinical trials and marketing. Yet, this small patient advocacy group is stunned by pharma’s pricing. → Read More
As An Investor In Biotech Stock, Republican Chris Collins May Have Overshared
Rep. Chris Collins talked one time too many, according to federal prosecutors who on Wednesday charged him with violating insider trading laws. → Read More
Patient Advocacy Groups Take in Millions From Drugmakers. Is There a Payback?
A new database tallies money from Big Pharma to patient groups. → Read More
Exclusive: White House Task Force Echoes Pharma Proposals
Documents examined by Kaiser Health News shed light on the workings of the Trump administration’s “Drug Pricing and Innovation Working Group.” → Read More
Exclusive: White House Task Force Echoes Pharma Proposals
Documents examined by Kaiser Health News shed light on the workings of the Trump administration’s “Drug Pricing and Innovation Working Group.” → Read More
Exclusive: White House Task Force Echoes Pharma Proposals
Documents examined by Kaiser Health News shed light on the workings of the Trump administration’s “Drug Pricing and Innovation Working Group.” → Read More
Tweet Revenge: Twitter Erupts As Diabetes Forum Tries To Lock Down Photo Sharing
This year’s American Diabetes Association scientific meeting comes with a hefty price — a policy of no photography and limits on social media. That did not go over well on Twitter. → Read More
Tweet Revenge: Twitter Erupts As Diabetes Forum Tries To Lock Down Photo Sharing
This year’s American Diabetes Association scientific meeting came with a hefty price — a policy of no photography and limits on social media. That did not go over well on Twitter. → Read More
Tweet Revenge: Twitter Erupts As Diabetes Forum Tries To Lock Down Photo Sharing
This year’s American Diabetes Association scientific meeting came with a hefty price — a policy of no photography and limits on social media. That did not go over well on Twitter. → Read More
Daylight On Diabetes Drugs: Nevada Bill Would Track Insulin Makers’ Profits
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices. → Read More
Daylight On Diabetes Drugs: Nevada Bill Would Track Insulin Makers’ Profits
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices. → Read More
Daylight On Diabetes Drugs: Nevada Bill Would Track Insulin Makers’ Profits
With the cost of medications up 300 percent in the past decade, supporters see this as a first step to rein in prices. → Read More
Rachel Bluth | Kaiser Health News
Rachel Bluth, Peggy Girshman Web Reporting Fellow, recently earned her master’s from the Philip Merrill College of Journalism at the University of Maryland. At Merrill, she reported on health disparities in Baltimore, and her work was published on npr.org and pbs.org. She was previously the lead political correspondent for the Annapolis Bureau of Capital News Service, where she covered the… → Read More
Report: Congressional Ethics Office Probing Rep. Chris Collins’ Aussie Investment
The Buffalo News reports the Buffalo, N.Y.-area Republican has drawn inquiries from the Office of Congressional Ethics related to his investment in Australian biotech company Innate Immunotherapeutics. → Read More
Report: Congressional Ethics Office Probing Rep. Chris Collins’ Aussie Investment
The Buffalo News reports the Buffalo, N.Y.-area Republican has drawn inquiries from the Office of Congressional Ethics related to his investment in Australian biotech company Innate Immunotherapeutics. → Read More
Non-Profit Linked To PhRMA Rolls Out Campaign To Block Drug Imports
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group. → Read More
Nonprofit Linked To PhRMA Rolls Out Campaign To Block Drug Imports
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group. → Read More
Nonprofit Linked To PhRMA Rolls Out Campaign To Block Drug Imports
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group. → Read More
Senators Demand Answers About Possible Probe Of HHS Secretary Price
Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him. → Read More
Senators Demand Answers About Possible Probe Of HHS Secretary Price
Democratic senators want the Justice Department to reveal what it knows about ProPublica’s recent report that HHS Secretary Tom Price’s stock trades were under investigation by former U.S. Attorney Preet Bharara before the Trump administration fired him. → Read More